BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 28
• 29
• 30
• 31

• Business

  Xenon Pharmaceuticals Reports First Quarter 2023 Financial Results and Provides Corporate Update

  Xenon Pharmaceuticals Inc., a neurology-focused biopharmaceutical company, reported financial results for the first quarter ended March 31, 2023 and provided a corporate update.

  May 9, 2023

   · 

  12 min read
• Business

  Arcutis Announces First Quarter 2023 Financial Results and Provides Business Update

  Arcutis Biotherapeutics, Inc., an early commercial-stage biopharmaceutical company focused on developing meaningful innovations in immuno-dermatology, reported financial results for the quarter ended March 31, 2023, and provided a business update.

  May 9, 2023

   · 

  10 min read
• Business

  Mirati Therapeutics Reports First Quarter 2023 Financial Results and Recent Corporate Updates

  Mirati Therapeutics, Inc.® (NASDAQ: MRTX), a commercial stage biotechnology company, today announced financial results for the first quarter 2023 along with recent pipeline and corporate updates.

  May 9, 2023

   · 

  10 min read
• Business

  Invitae Reports First Quarter 2023 Financial Results

  Invitae, a leading medical genetics company, announced financial and operating results for the first quarter ended March 31, 2023.

  May 9, 2023

   · 

  17 min read
• Business

  Avidity Biosciences Reports First Quarter 2023 Financial Results and Recent Highlights

  Avidity Biosciences, Inc., a biopharmaceutical company committed to delivering a new class of RNA therapeutics called Antibody Oligonucleotide Conjugates, reported financial results for the first quarter ended March 31, 2023 and highlighted recent corporate progress.

  May 9, 2023

   · 

  11 min read
• Pharm Country

  Marinus Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4) - May 09, 2023

  Marinus Pharmaceuticals, Inc., a pharmaceutical company dedicated to the development of innovative therapeutics to treat seizure disorders, announced the grant of inducement awards to five new employees.

  May 9, 2023

   · 

  3 min read
• Business

  Quanterix Releases Operating Results for First Quarter 2023

  Quanterix Corporation, a company fueling scientific discovery through ultrasensitive biomarker detection, announced financial results for the three months ended March 31, 2023.

  May 9, 2023

   · 

  10 min read
• Business

  Longboard Pharmaceuticals Provides Corporate Update and Reports First Quarter 2023 Financial Results

  Longboard Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company focused on developing novel, transformative medicines for neurological diseases, provided a corporate update and reported financial results for the first quarter ended March 31, 2023.

  May 9, 2023

   · 

  9 min read
• Biotech Bay

  CooperCompanies Publishes 2022 Environmental, Social, and Governance Report, Shares Progress on Creating Value for Stakeholders

  CooperCompanies released its 2022 Environmental, Social, and Governance Report.

  May 9, 2023

   · 

  4 min read
• Business

  Janux Therapeutics Reports First Quarter 2023 Financial Results and Business Highlights

  Janux Therapeutics, Inc. (Nasdaq: JANX) (Janux), today reported financial results for the first quarter ended March 31, 2023 and provided a business update.

  May 9, 2023

   · 

  8 min read